Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity

<p dir="ltr">Quinoxaline is a heterocyclic compound with a two-membered ring structure that undergoes redox cycling to produce toxic free radicals. It has antiviral, antibacterial, antifungal, and antitumor activities. However, the biological functions that are involved in mounting a...

Full description

Saved in:
Bibliographic Details
Main Author: Abdallah Alhaj Sulaiman (17777421) (author)
Other Authors: Dana E. Al-Ansari (16327350) (author), Reem Ali (9913494) (author), Mustapha Aouida (417652) (author), Dindial Ramotar (208416) (author)
Published: 2024
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513510223904768
author Abdallah Alhaj Sulaiman (17777421)
author2 Dana E. Al-Ansari (16327350)
Reem Ali (9913494)
Mustapha Aouida (417652)
Dindial Ramotar (208416)
author2_role author
author
author
author
author_facet Abdallah Alhaj Sulaiman (17777421)
Dana E. Al-Ansari (16327350)
Reem Ali (9913494)
Mustapha Aouida (417652)
Dindial Ramotar (208416)
author_role author
dc.creator.none.fl_str_mv Abdallah Alhaj Sulaiman (17777421)
Dana E. Al-Ansari (16327350)
Reem Ali (9913494)
Mustapha Aouida (417652)
Dindial Ramotar (208416)
dc.date.none.fl_str_mv 2024-01-12T09:00:00Z
dc.identifier.none.fl_str_mv 10.3389/fgene.2023.1296383
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Mft1_identified_from_a_genome-wide_screen_of_the_yeast_haploid_mutants_mediates_cell_cycle_arrest_to_counteract_quinoxaline-induced_toxicity/26389078
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Biochemistry and cell biology
Genetics
Biomedical and clinical sciences
Clinical sciences
Saccharomyces cerevisiae
quinoxaline sensitive mutants
cell cycle arrest
genome-wide screening
drug resistance
antibacterial
antifungal
antitumor activities
dc.title.none.fl_str_mv Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Quinoxaline is a heterocyclic compound with a two-membered ring structure that undergoes redox cycling to produce toxic free radicals. It has antiviral, antibacterial, antifungal, and antitumor activities. However, the biological functions that are involved in mounting a response against the toxic effects of quinoxaline have not been investigated. Herein, we performed a genome-wide screen using the yeast haploid mutant collection and reported the identification of 12 mutants that displayed varying sensitivity towards quinoxaline. No mutant was recovered that showed resistance to quinoxaline. The quinoxaline-sensitive mutants were deleted for genes that encode cell cycle function, as well as genes that belong to other physiological pathways such as the vacuolar detoxification process. Three of the highly sensitive gene-deletion mutants lack the DDC1,<i> DUN1</i>, and <i>MFT1</i> genes. While Ddc1 and Dun1 are known to perform roles in the cell cycle arrest pathway, the role of Mft1 remains unclear. We show that the <i>mft1Δ</i> mutant is as sensitive to quinoxaline as the <i>ddc1Δ </i>mutant. However, the double mutant <i>ddc1Δ mft1Δ</i> lacking the <i>DDC1</i> and <i>MFT1</i> genes, is extremely sensitive to quinoxaline, as compared to the<i> ddc1Δ</i> and <i>mft1Δ</i> single mutants. We further show that the mft1Δ mutant is unable to arrest in the G2/M phase in response to the drug. We conclude that Mft1 performs a unique function independent of Ddc1 in the cell cycle arrest pathway in response to quinoxaline exposure. This is the first demonstration that quinoxaline exerts its toxic effect likely by inducing oxidative DNA damage causing cell cycle arrest. We suggest that clinical applications of quinoxaline and its derivatives should entail targeting cancer cells with defective cell cycle arrest.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Genetics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fgene.2023.1296383" target="_blank">https://dx.doi.org/10.3389/fgene.2023.1296383</a></p>
eu_rights_str_mv openAccess
id Manara2_4e016be53c158183ac0ad965aff8b58e
identifier_str_mv 10.3389/fgene.2023.1296383
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/26389078
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicityAbdallah Alhaj Sulaiman (17777421)Dana E. Al-Ansari (16327350)Reem Ali (9913494)Mustapha Aouida (417652)Dindial Ramotar (208416)Biological sciencesBiochemistry and cell biologyGeneticsBiomedical and clinical sciencesClinical sciencesSaccharomyces cerevisiaequinoxaline sensitive mutantscell cycle arrestgenome-wide screeningdrug resistanceantibacterialantifungalantitumor activities<p dir="ltr">Quinoxaline is a heterocyclic compound with a two-membered ring structure that undergoes redox cycling to produce toxic free radicals. It has antiviral, antibacterial, antifungal, and antitumor activities. However, the biological functions that are involved in mounting a response against the toxic effects of quinoxaline have not been investigated. Herein, we performed a genome-wide screen using the yeast haploid mutant collection and reported the identification of 12 mutants that displayed varying sensitivity towards quinoxaline. No mutant was recovered that showed resistance to quinoxaline. The quinoxaline-sensitive mutants were deleted for genes that encode cell cycle function, as well as genes that belong to other physiological pathways such as the vacuolar detoxification process. Three of the highly sensitive gene-deletion mutants lack the DDC1,<i> DUN1</i>, and <i>MFT1</i> genes. While Ddc1 and Dun1 are known to perform roles in the cell cycle arrest pathway, the role of Mft1 remains unclear. We show that the <i>mft1Δ</i> mutant is as sensitive to quinoxaline as the <i>ddc1Δ </i>mutant. However, the double mutant <i>ddc1Δ mft1Δ</i> lacking the <i>DDC1</i> and <i>MFT1</i> genes, is extremely sensitive to quinoxaline, as compared to the<i> ddc1Δ</i> and <i>mft1Δ</i> single mutants. We further show that the mft1Δ mutant is unable to arrest in the G2/M phase in response to the drug. We conclude that Mft1 performs a unique function independent of Ddc1 in the cell cycle arrest pathway in response to quinoxaline exposure. This is the first demonstration that quinoxaline exerts its toxic effect likely by inducing oxidative DNA damage causing cell cycle arrest. We suggest that clinical applications of quinoxaline and its derivatives should entail targeting cancer cells with defective cell cycle arrest.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Genetics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fgene.2023.1296383" target="_blank">https://dx.doi.org/10.3389/fgene.2023.1296383</a></p>2024-01-12T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fgene.2023.1296383https://figshare.com/articles/journal_contribution/Mft1_identified_from_a_genome-wide_screen_of_the_yeast_haploid_mutants_mediates_cell_cycle_arrest_to_counteract_quinoxaline-induced_toxicity/26389078CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/263890782024-01-12T09:00:00Z
spellingShingle Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
Abdallah Alhaj Sulaiman (17777421)
Biological sciences
Biochemistry and cell biology
Genetics
Biomedical and clinical sciences
Clinical sciences
Saccharomyces cerevisiae
quinoxaline sensitive mutants
cell cycle arrest
genome-wide screening
drug resistance
antibacterial
antifungal
antitumor activities
status_str publishedVersion
title Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
title_full Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
title_fullStr Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
title_full_unstemmed Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
title_short Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
title_sort Mft1, identified from a genome-wide screen of the yeast haploid mutants, mediates cell cycle arrest to counteract quinoxaline-induced toxicity
topic Biological sciences
Biochemistry and cell biology
Genetics
Biomedical and clinical sciences
Clinical sciences
Saccharomyces cerevisiae
quinoxaline sensitive mutants
cell cycle arrest
genome-wide screening
drug resistance
antibacterial
antifungal
antitumor activities